{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T12:22:32Z","timestamp":1789734152633,"version":"4.0.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2005,12,7]],"date-time":"2005-12-07T00:00:00Z","timestamp":1133913600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1007\/s00259-005-1954-1","type":"journal-article","created":{"date-parts":[[2005,12,6]],"date-time":"2005-12-06T11:29:16Z","timestamp":1133868556000},"page":"344-352","source":"Crossref","is-referenced-by-count":26,"title":["188Re-HDD\/lipiodol therapy for hepatocellular carcinoma: an activity escalation study"],"prefix":"10.1007","volume":"33","author":[{"given":"Bieke","family":"Lambert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Bacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Defreyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Van Vlierberghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Min","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong Fu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"van Meerbeeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Smeets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Troisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Thierens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"De Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Van de Wiele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,12,7]]},"reference":[{"key":"1954_CR1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ijc.1440","volume":"94","author":"MD Parkin","year":"2001","unstructured":"Parkin MD, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: globocan 2000. Int J Cancer 2001;94:153\u20136","journal-title":"Int J Cancer"},{"key":"1954_CR2","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJM199903113401001","volume":"340","author":"HB El-Serag","year":"1999","unstructured":"El-Serag HB, Masson AC. Rising incidence of hepatocellular carcinoma in the United States. N Eng J Med 1999;340:745\u201350","journal-title":"N Eng J Med"},{"key":"1954_CR3","doi-asserted-by":"crossref","first-page":"817","DOI":"10.7326\/0003-4819-139-10-200311180-00009","volume":"139","author":"HB El-Serag","year":"2003","unstructured":"El-Serag HB, Davila JA, Petersen NJ, McGlynn KA. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 2003;139:817\u201323","journal-title":"Ann Intern Med"},{"key":"1954_CR4","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0140-6736(98)09148-X","volume":"353","author":"DF Schafer","year":"1999","unstructured":"Schafer DF, Sorrell MF. Hepatocellular carcinoma. Lancet 1999;353:1253\u20137","journal-title":"Lancet"},{"key":"1954_CR5","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1054\/bjoc.2001.1769","volume":"84","author":"M Giovannini","year":"2001","unstructured":"Giovannini M, Elias D, Monges G, Raoul JL, Rougier P. Hepatocellular carcinoma. Br J Cancer 2001;84:74\u20137","journal-title":"Br J Cancer"},{"key":"1954_CR6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","volume":"35","author":"J Bruix","year":"2001","unstructured":"Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001;35:421\u201330","journal-title":"J Hepatol"},{"key":"1954_CR7","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/jhep.2003.50047","volume":"37","author":"JM Llovet","year":"2003","unstructured":"Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003;37:429\u201342","journal-title":"Hepatology"},{"key":"1954_CR8","first-page":"1156","volume":"26","author":"JL Raoul","year":"1997","unstructured":"Raoul JL, Guyader D, Bretagne JF, Heautot JF, Duvauferrier R, Bourguet P, et al. Prospective randomized trial of chemoembolization versus intra-arterial injection of 131-I-iodized oil in the treatment of hepatocellular carcinoma. Hepatology 1997;26:1156\u201361","journal-title":"Hepatology"},{"key":"1954_CR9","first-page":"1313","volume":"35","author":"WT Leung","year":"1994","unstructured":"Leung WT, Lau WY, Ho S, Chan M, Leung N, Lin J, et al. Selective internal radiation therapy with intra-arterial iodine-131-lipiodol in inoperable hepatocellular carcinoma. J Nucl Med 1994;35:1313\u20138","journal-title":"J Nucl Med"},{"key":"1954_CR10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1089\/cbr.2000.15.65","volume":"15","author":"JH Risse","year":"2000","unstructured":"Risse JH, Gr\u00fcnwald F, Kersjes W, Strunk H, Caselmann WH, Palmedo H, et al. Intra arterial HCC therapy with 131I-lipiodol. Cancer Biother Radiopharm 2000;15:65\u201370","journal-title":"Cancer Biother Radiopharm"},{"key":"1954_CR11","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1089\/cbr.1998.13.337","volume":"13","author":"FF Knapp","year":"1998","unstructured":"Knapp FF. Rhenium-188\u2014a generator-derived radioisotope for cancer therapy. Cancer Biother Radiopharm 1998;13:337\u201349","journal-title":"Cancer Biother Radiopharm"},{"key":"1954_CR12","first-page":"5","volume":"1","author":"FX Sundram","year":"2002","unstructured":"Sundram FX, Jeong JM, Zanzonico P, et al. Trans-arterial rhenium-188 lipiodol in the treatment of inoperable hepatocellular carcinoma. An IAEA sponsored multi-centre phase 1 study. World J Nucl Med 2002;1:5\u201311","journal-title":"World J Nucl Med"},{"key":"1954_CR13","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s00259-003-1363-2","volume":"31","author":"F Sundram","year":"2004","unstructured":"Sundram F, Chau TC, Onkhuudai P, Bernal P, Padhy AK. Preliminary results of transarterial rhenium-188 HDD lipiodol in the treatment of inoperable primary hepatocellular carcinoma. Eur J Nucl Med Mol Imaging 2004;31:250\u20137","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1954_CR14","first-page":"60","volume":"46","author":"B Lambert","year":"2005","unstructured":"Lambert B, Bacher K, Defreyne L, Gemmel F, Van Vlierberghe H, Jeong JM, et al. 188Re-HDD\/lipiodol therapy for hepatocellular carcinoma: a phase I clinical trial. J Nucl Med 2005;46:60\u20136","journal-title":"J Nucl Med"},{"key":"1954_CR15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0969-8051(00)00208-0","volume":"28","author":"JM Jeong","year":"2001","unstructured":"Jeong JM, Kim YJ, Lee YS, Ko JI, Son M, Lee DS, et al. Lipiodol solution of a lipophilic agent, 188-Re-TDD, for the treatment of liver cancer. Nucl Med Biol 2001;28:197\u2013204","journal-title":"Nucl Med Biol"},{"key":"1954_CR16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00006231-200203000-00006","volume":"23","author":"YS Lee","year":"2002","unstructured":"Lee YS, Jeong JM, Kim YJ, Chung JW, Park JH, Suh YG, et al. Synthesis of 188Re-labelled long chain alkyl diaminedithiol for therapy of liver cancer. Nucl Med Commun 2002;23:237\u201342","journal-title":"Nucl Med Commun"},{"key":"1954_CR17","first-page":"1271","volume":"4","author":"S Guhlke","year":"2000","unstructured":"Guhlke S, Beets AL, Oetjen K, Mirzadeh S, Biersack HJ, Knapp FF Jr. Simple new method for effective concentration of Re-188 solutions from alumina-based W-188\u2013Re-188 generator. J Nucl Med 2000;4:1271\u20138","journal-title":"J Nucl Med"},{"key":"1954_CR18","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","volume":"60","author":"RN Pugh","year":"1973","unstructured":"Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646\u20139","journal-title":"Br J Surg"},{"key":"1954_CR19","volume-title":"MIRD primer for absorbed dose calculations","author":"R Loevinger","year":"1991","unstructured":"Loevinger R, Budinger TF, Watson EE. MIRD primer for absorbed dose calculations. New York: The Society of Nuclear Medicine, 1991"},{"key":"1954_CR20","first-page":"538","volume":"37","author":"MG Stabin","year":"1996","unstructured":"Stabin MG. MIRDOSE: personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 1996;37:538\u201346","journal-title":"J Nucl Med"},{"key":"1954_CR21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 2000;92:205\u201316","journal-title":"J Natl Cancer Inst"},{"key":"1954_CR22","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E","volume":"56","author":"K Okuda","year":"1985","unstructured":"Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Cancer 1985;56:918\u201328","journal-title":"Cancer"},{"key":"1954_CR23","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/hep.510280322","volume":"28","author":"The Cancer of the Liver Italian Program (CLIP) investigators","year":"1998","unstructured":"The Cancer of the Liver Italian Program (CLIP) investigators. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology 1998;28:751\u20135","journal-title":"Hepatology"},{"key":"1954_CR24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00006231-200304000-00008","volume":"24","author":"B Brans","year":"2003","unstructured":"Brans B, Bacher K, Vandevyver V, Vanlangenhove P, Smeets P, Thierens H, et al. Intra-arterial radionuclide therapy for liver tumours: effect of selectivity of catheterization and 131I-lipiodol delivery on tumour uptake and response. Nucl Med Commun 2003;24:391\u20136","journal-title":"Nucl Med Commun"},{"key":"1954_CR25","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1148\/radiology.168.2.2839866","volume":"168","author":"JL Raoul","year":"1988","unstructured":"Raoul JL, Bourguet P, Bretagne JF, Duvauferrier R, Coornaert S, Darnault P, et al. Hepatic artery injection of I-131-labeled lipiodol. Biodistribution study results in patients with hepatocellular carcinoma and liver metastases. Radiology 1988;168:541\u20135","journal-title":"Radiology"},{"key":"1954_CR26","first-page":"1066","volume":"29","author":"M Nakajo","year":"1988","unstructured":"Nakajo M, Kobayashi H, Shimabukuro K, Shirono K, Sakata H, Taguchi M, et al. Biodistribution and in vivo kinetics of iodine-131 lipiodol infused via the hepatic artery of patients with hepatic cancer. J Nucl Med 1988;29:1066\u201377","journal-title":"J Nucl Med"},{"key":"1954_CR27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1089\/cbr.2005.20.209","volume":"20","author":"B Lambert","year":"2005","unstructured":"Lambert B, Praet M, Vanlangenhove P, Troisi R, de Hemptinne B, Gemmel F, et al. Radiolabelled lipiodol therapy for hepatocellular carcinoma in patients awaiting liver transplantation: pathology of the explant livers and clinical outcome. Cancer Biother Radiopharm 2005:20:209\u201314","journal-title":"Cancer Biother Radiopharm"},{"key":"1954_CR28","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/01.mnm.0000130241.22068.45","volume":"25","author":"A Boschi","year":"2004","unstructured":"Boschi A, Uccelli L, Duatti A, Colamussi P, Cittanti C, Filice A, et al. A kit formulation for the preparation of 188Re-lipiodol: preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma. Nucl Med Commun 2004; 25:691\u20139","journal-title":"Nucl Med Commun"},{"key":"1954_CR29","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s00259-003-1402-z","volume":"31","author":"E Garin","year":"2004","unstructured":"Garin E, Noiret N, Malbert C, Lepareur N, Roucoux A, Caulet-Maugendre S, et al. Development and biodistribution of 188Re-SSS lipiodol following injection into the hepatic artery of healthy pigs. Eur J of Nucl Med Mol Imaging 2004;31:542\u20136","journal-title":"Eur J of Nucl Med Mol Imaging"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-005-1954-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-005-1954-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-005-1954-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T11:58:53Z","timestamp":1558699133000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-005-1954-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12,7]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["1954"],"URL":"https:\/\/doi.org\/10.1007\/s00259-005-1954-1","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12,7]]}}}